Other Events ·
Incyte Corporation held its Annual Meeting of Shareholders on June 8, 2026, where shareholders elected eight…
INCYIncyte Corp
Incyte Corporation held its Annual Meeting of Shareholders on June 8, 2026, where shareholders elected eight directors, approved non-binding advisory compensation for named executive officers, and ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Incyte Corporation is a biotechnology company that develops and commercializes therapeutic products.